David Cantor - Vycor Medical Pres and Director
| VYCO Stock | USD 0.07 0 1.45% |
Director
Mr. David Marc Cantor is President and Director of the Company. Mr. Cantor was President of the Company since September 2010 and a Director since January 2010. He is an investment manager of Fountainhead Capital Management Limited, an investment company based in Jersey, Channel Islands, which invests in, raises capital for and provides strategic advice to growth companies across a broad range of sectors. Mr. Cantor has over 22 years experience in Investment Banking with a focus on Mergers and Acquisitions and Equity Capital Raisings. Prior to Fountainhead from 2001 2005 he was at Citigroup Capital Markets where he was Cohead of its European Business Development Group and subsequently European Head of its Diversified Industrials and Aerospace activities. Prior to Citigroup he was a Managing Director in MA at Donaldson Lufkin Jenrette and worked at Lehman Brothers both in New York and London in both the Equity Capital and MA groups since 2010.
| Age | 57 |
| Tenure | 14 years |
| Phone | 561 558 2000 |
| Web | https://www.vycormedical.com |
Vycor Medical Management Efficiency
The company has return on total asset (ROA) of (0.2385) % which means that it has lost $0.2385 on every $100 spent on assets. This is way below average. Vycor Medical's management efficiency ratios could be used to measure how well Vycor Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | DIRECTOR Age | ||
| Joel Suiter | SurModics | N/A | |
Management Performance
| Return On Asset | -0.24 |
Vycor Medical Management Team
Elected by the shareholders, the Vycor Medical's board of directors comprises two types of representatives: Vycor Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vycor. The board's role is to monitor Vycor Medical's management team and ensure that shareholders' interests are well served. Vycor Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vycor Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adrian Liddell, Chairman, CFO, Principal Accounting Officer and Member of Audit Committee | ||
| Peter Zachariou, CEO and Director | ||
| David Cantor, Pres and Director |
Vycor Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Vycor Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.24 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.31) % | |||
| Current Valuation | 4.17 M | |||
| Shares Outstanding | 32.53 M | |||
| Shares Owned By Insiders | 64.50 % | |||
| Price To Earning | (2.74) X | |||
| Price To Sales | 2.60 X | |||
| Revenue | 1.39 M | |||
| Gross Profit | 1.26 M |
Pair Trading with Vycor Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vycor Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vycor Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Vycor OTC Stock
| 0.45 | OPTX | Syntec Optics Holdings Trending | PairCorr |
| 0.39 | MMV | MultiMetaVerse Holdings | PairCorr |
| 0.34 | THCPU | Thunder Bridge Capital | PairCorr |
The ability to find closely correlated positions to Vycor Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vycor Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vycor Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vycor Medical to buy it.
The correlation of Vycor Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vycor Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vycor Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vycor Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.